Contact

Partner/Owner

Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

We have observed 22 EP applications Andreas Ledl has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 25, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13748684

THERMOSENSITIVE NANOPARTICLE FORMULATIONS AND METHOD OF MAKING THE SAME

IPC classification:
A61K 9/127
Applicant:
Celsion Corporation
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13722381

INTRA-OPERATIVE CANCER DIAGNOSIS BASED ON A HYPERPOLARIZED MARKER

IPC classification:
G01N 33/574
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13786679

SUBSTITUTED TRICYCLIC BENZIMIDAZOLES AS KINASE INHIBITORS

IPC classification:
A61K 31/4188, C07D 471/06, C07D 487/06
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP13815453

PREDICTION OF THE TREATMENT RESPONSE TO AN ANTI-EGFR MOLECULE IN COLORECTAL CANCER PATIENTS

IPC classification:
C12Q 1/68
Applicant:
Graz University of Medicine (Medizinische Universit├Ąt Graz)
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP15180143

DOSAGE FORM CONTAINING OXYCODONE AND NALOXONE

IPC classification:
A61K 9/28, A61K 31/485, A61P 25/04
Applicant:
Euro-Celtique S.A.
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14705370

PYRIDINE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/444, A61P 25/00, C07D 405/06, C07D 405/14
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP11802440

A COMBINATION OF AN OPIOID AGONIST AND AN OPIOID ANTAGONIST IN THE TREATMENT OF PARKINSON'S DISEASE

IPC classification:
A61K 9/00, A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/485, A61K 45/06, A61P 1/10, A61P 25/00, A61P 25/02, A61P 25/14, A61P 25/16
Applicant:
Euro-Celtique S.A.
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14832793

VACCINE FORMULATIONS THAT INDUCE A TH2 IMMUNE RESPONSE

IPC classification:
A61K 39/00, A61P 25/28, B01F 17/56
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP15839303

SWEETNESS ENHANCER

IPC classification:
C07C 39/10
Applicant:
PepsiCo Inc
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15794766

IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/445, A61P 31/12, C07D 211/46, C07D 401/06, C07D 401/12, C07D 405/06, C07D 409/06, C07D 413/06, C07D 473/34, C07D 487/04
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP17154428

ALCOHOL RESISTANT DOSAGE FORMS

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/00
Applicant:
Euro-Celtique S.A.
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP17154462

MATRIX FOR SUSTAINED, INVARIANT AND INDEPENDENT RELEASE OF ACTIVE COMPOUNDS

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/485
Applicant:
Euro-Celtique S.A.
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16737872

BEVERAGE COOLING

IPC classification:
F25D 23/00
Applicant:
PepsiCo Inc
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16753041

STABILIZING SORBIC ACID IN BEVERAGE SYRUP

IPC classification:
A23L 2/39, A23L 2/52, A23L 3/46
Applicant:
PepsiCo Inc
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16705961

INTERACTION OF METHYLATED LSD1 AND CHD1, A COMPOUND INHIBITING THIS INTERACTION FOR USE IN THERAPY, AND A SCREENING METHOD FOR SUCH A COMPOUND

IPC classification:
A61K 31/00, A61P 35/00, G01N 33/68
Applicant:
University of Freiburg (Albert-Ludwigs-Universit├Ąt Freiburg)
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16769371

COOLING SYSTEM AND METHOD

IPC classification:
A47F 3/04, F25D 3/02, F25D 17/06, F25D 17/08
Applicant:
PepsiCo Inc
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16774182

METHOD OF MEASURING CARBONATION LEVELS IN OPEN-CONTAINER BEVERAGES

IPC classification:
G01J 5/00
Applicant:
PepsiCo Inc
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16723018

SUBSTITUTED QUINOXALINE DERIVATIVES

IPC classification:
A61K 31/498, A61P 35/00, C07D 401/14, C07D 403/04, C07D 407/14, C07D 417/14, C07D 419/14, C07D 471/04
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16797295

DIGITAL TABLE

IPC classification:
A47G 19/22, A47J 31/40, B65B 3/04, B67C 3/26, B67D 1/08
Applicant:
PepsiCo Inc
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP17177795

FUSION POLYPEPTIDES OF ANTIBODIES THAT BIND CELL-ASSOCIATED CA 125/O722P

IPC classification:
A61K 39/395, C07H 21/04, C07K 16/00, C12N 5/12, G01N 33/53
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
The application has been published
EP16780879

PRINTED USER INTERFACE

IPC classification:
B67D 7/00, B67D 7/06, B67D 7/08, G06F 3/041, G06F 3/042, G06F 3/043, G06F 3/044
Applicant:
PepsiCo Inc
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP17208976

INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE

IPC classification:
A61K 9/00, A61K 9/08, A61K 31/135, A61P 25/36
Applicant:
Euro-Celtique S.A.
Agent:
Andreas Ledl, Maiwald Patentanwalts GmbH
Status:
Request for examination was made

Please Sign in to use this feature